_8_4(1)-min_15.png "Vetted Talents logo")
Recode Therapeutics
OtherGenetic MedicinesCystic FibrosisBiotechnology
Overview
ReCode Therapeutics is a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics. ReCode’s selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a next-generation, genetic medicines technology that enables precise delivery to target organs and cells beyond the liver.